Patrick Balaguer

Dr. Patrick Balaguer

Inserm
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
LTLucia Toporova
Lucia Toporova
Patrick BalaguerPatrick Balaguer
Patrick Balaguer

3 September 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
VDVanessa Delfosse
Vanessa Delfosse
BDBéatrice Dendele
Béatrice Dendele
THTiphaine Huet
Tiphaine Huet
MGMarina Grimaldi
Marina Grimaldi
ABAbdelhay Boulahtouf
Abdelhay Boulahtouf
WBWilliam Bourguet
William Bourguet
Humans are chronically exposed to multiple exogenous substances, including environmental pollutants, drugs and dietary components. Many of these compounds are suspected to impact human health, and their combination in complex mixtures could exacerbate their harmful effects. Here we demonstrate that a pharmaceutical oestrogen and a persistent organochlorine pesticide, both exhibiting low efficacy when studied separately, cooperatively bind to the pregnane X receptor, leading to synergistic activation. Biophysical analysis shows that each ligand enhances the binding affinity of the other, so the binary mixture induces a substantial biological response at doses at which each chemical individually is inactive. High-resolution crystal structures reveal the structural basis for the observed cooperativity. Our results suggest that the formation of ‘supramolecular ligands’ within the ligand-binding pocket of nuclear receptors contributes to the synergistic toxic effect of chemical mixtures, which may have broad implications for the fields of endocrine disruption, toxicology and chemical risk assessment.

16 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JGJakub Gruszczyk
Jakub Gruszczyk
LGLoïc Grandvuillemin
Loïc Grandvuillemin
JLJosephine Lai-Kee-Him
Josephine Lai-Kee-Him
MPMatteo Paloni
Matteo Paloni
CSChristos G. Savva
Christos G. Savva
WBWilliam Bourguet
William Bourguet
The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor that mediates a broad spectrum of (patho)physiological processes in response to numerous substances including pollutants, natural products and metabolites. However, the scarcity of structural data precludes understanding of how AHR is activated by such diverse compounds. Our 2.85 Å structure of the human indirubin-bound AHR complex with the chaperone Hsp90 and the co-chaperone XAP2, reported herein, reveals a closed conformation Hsp90 dimer with AHR threaded through its lumen and XAP2 serving as a brace. Importantly, we disclose the long-awaited structure of the AHR PAS-B domain revealing a unique organisation of the ligand-binding pocket and the structural determinants of ligand-binding specificity and promiscuity of the receptor. By providing structural details of the molecular initiating event leading to AHR activation, our study rationalises almost forty years of biochemical data and provides a framework for future mechanistic studies and structure-guided drug design.

7 February 2017 in ChemSusChem
Verified
Journal Article
Closed access
PDF file
MJMarine Janvier
Marine Janvier
LHLouis Hollande
Louis Hollande
AJAbdus Samad Jaufurally
Abdus Samad Jaufurally
MPMiguel Pernes
Miguel Pernes
RMRaphaël Ménard
Raphaël Ménard
Florent AllaisFlorent Allais
Florent Allais

1 May 2019 in Toxicology
Verified
Journal Article
Closed access
MGMarina Grimaldi
Marina Grimaldi
ABAbdelhay Boulahtouf
Abdelhay Boulahtouf
LTLucia Toporova
Lucia Toporova
Patrick BalaguerPatrick Balaguer
Patrick Balaguer

11 May 2015 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
MGMarina Grimaldi
Marina Grimaldi
ABAbdelhay Boulahtouf
Abdelhay Boulahtouf
VDVanessa Delfosse
Vanessa Delfosse
ETErwan Thouennon
Erwan Thouennon
WBWilliam Bourguet
William Bourguet
Patrick BalaguerPatrick Balaguer
Patrick Balaguer
Endocrine-disrupting chemicals (EDCs) are exogenous substances interfering with hormone biosynthesis, metabolism, or action, and consequently causing disturbances in the endocrine system. Various pathways are activated by EDCs, including interactions with nuclear receptors (NRs) which are primary targets of numerous environmental contaminants. The main NRs targeted by environmental contaminants are the estrogen (ER α, β) and the androgen (AR) receptors. ERs and AR have pleiotropic regulatory roles in a diverse range of tissues, notably in the mammary gland, the uterus and the prostate. Thus, dysfunctional ERs and AR signaling due to inappropriate exposure to environmental pollutants may lead to hormonal cancers and infertility. The pregnane X receptor (PXR) is also recognized by many environmental molecules. PXR has a protective role of the body through its ability to regulate proteins involved in the metabolism, the conjugation and the transport of many exogenous and endogenous compounds. However, the permanent activation of this receptor by xenobiotics may lead to premature drug metabolism, the formation and accumulation of toxic metabolites and defects in hormones homeostasis. The activity of other NRs can also be affected by environmental molecules. Compounds capable of inhibiting or activating the estrogen related (ERRγ), the thyroid hormone (TRα, β), the retinoid X receptors (RXRα, β, γ) and peroxisome proliferator-activated (PPAR α, γ) receptors have been identified and are highly suspected to promote developmental, reproductive, neurological, or metabolic diseases in humans and wildlife. In this review we provide an overview of reporter cell lines established to characterize the human NR activities of a large panel of EDCs including natural as well as industrial compounds such as pesticides, plasticizers, surfactants, flame retardants and cosmetics.